Business

New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.

New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc..

articleEndonovo Therapeutics, Inc.June 22, 20233/company/endonovo-therapeutics-inc/news/new-to-the-street-tv-signs-6-part-series-featuring-endonovo-therapeutics-inc
New to The Street TV Signs 6 Part Series, Featuring Endonovo Therapeutics, Inc.

About this update from Endonovo Therapeutics, Inc.

[{"type":"text","content":"\n NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- FMW Media Works' New to The Street will feature Endonovo Therapeutics, Inc. (OTCQB: ENDV) ($ENDV) on its nationally syndicated and sponsored television program. The series will span six (6) months following Endonovo Therapeutics' business mission is to transform healthcare with FDA Cleared non-invasive medical and non-medical PEMF (Pulsed Electro Magnetic Field) devices while seamlessly developing and integrating telehealth platforms into its business model. TV Host Jane King will interview ENDV's management representatives, who will introduce themselves to New to The Street's viewers and provide ongoing updates about the Company's operations. Viewers will hear and learn more about Endonovo's integrative strategy, which involves leveraging their portfolio of 27 patented technologies and establishing strategic partnerships with top telehealth technology developers. The company has also secured international and domestic contracts, including distribution agreements with prestigious entities such as the US Department of Defense and VA. The highlight of company’s offerings is its FDA-Cleared Electroceutical® Therapy, SofPulse®, a patented treatment that effectively addresses the reduction of post-operative pain and edema. Endonovo’s future research and development will focus on expanding their patented range of wearable biotech devices to address inflammatory conditions, chronic pain, cardiovascular diseases, and central nervous system disorders including Multiple Sclerosis (MS), Alzheimer’s, Dementia and Traumatic Brain Injury (TBI). FMW Media will be producing and broadcasting the show across all of New to The Street's syndicated televised platforms on Newsmax, Fox Business Network, and as a sponsored program on Bloomberg TV. All broadcasted shows will stream for 18 months on the New to The Street website, www.newtothestreet.com. New to The Street will provide social media marketing to further the reach of each broadcast. On a schedule, show previews and commercial ads will air on selected New to The Street syndicated and sponsored TV platforms. Digital ads will stream on New to The Street's billboard platform throughout New York City. \"We are very excited to start working with FMW Media and look forward to updating our stakeholders with our late...

More updates from Endonovo Therapeutics, Inc.